Schizophrenia, tardive dyskinesia, and the Abnormal Involuntary Movement Scale (AIMS)
β Scribed by Menzies, V
- Book ID
- 122124976
- Publisher
- SAGE Publications
- Year
- 2002
- Tongue
- English
- Weight
- 101 KB
- Volume
- 8
- Category
- Article
- ISSN
- 1078-3903
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
We examined whether an oral challenge dose of the amino acid phenylalanine (a dopamine precursor) exacerbates the abnormal movements of tardive dyskinesia (TD). We also examined age, gender, treatment duration, and baseline movement severity in relation to phenylalanine-induced changes in movements.
## Abstract The US Department of Veterans' Affairs (VA) conducted Cooperative Study #394 at nine sites to determine whether vitamin E was a safe and effective treatment for tardive dyskinesia (TD). The study used the Abnormal Involuntary Movement Scale (AIMS) to measure TD. To monitor interβrater r